Learn more

MAXYGEN HOLDINGS LTD

Overview
  • Total Patents
    147
About

MAXYGEN HOLDINGS LTD has a total of 147 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are KAI PHARMACEUTICALS INC, INST SUPERIORE DI SANITA and CLARASSANCE INC.

Patent filings per year

Chart showing MAXYGEN HOLDINGS LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Andersen Kim Vilbour 65
#2 Hansen Christian Karsten 35
#3 Jensen Anne Dam 29
#4 Nissen Torben Lauesgaard 22
#5 Mikkelsen Jan Moller 21
#6 Bornaes Claus 20
#7 Schambye Hans Thalsgaard 19
#8 Andersen Kim V 16
#9 Haaning Jesper Mortensen 15
#10 Soni Bobby 14

Latest patents

Publication Filing date Title
WO2008147534A1 Method for the treatment of neutropenia by administration of a multi-pegylated granulocyte colony stimulating factor (g-csf) variant
EP1919498A2 Liquid factor vii composition
BRPI0611221A2 pegylated g-csf polypeptides and their production methods
EP1893230A2 Use of modified factor vii for treating bleeding
WO2005073375A1 Regulated stop codon readthrough
WO2005023308A1 Formulations of vitamin k-dependent polypeptides and sulfoalkyl ether cycloextrins
NZ587580A Factor VII or VIIa Gla domain variants
WO2004113385A1 Protein c propeptide variants
ZA200308376B Interferon gamma polypeptide variants.
CA2491178A1 Full-length interferon gamma polypeptide variants
BR0309576A Factor vii (fvii) or factor viia (fviia) polypeptide variant, nucleotide sequence, expression vector, host cell, pharmaceutical composition, use of a variant, and method for treating a mammal having a disease or disorder in that clot formation is desirable
US2003133907A1 Interferon gamma polypeptide variants
NZ530545A Specific conjugates comprising a polypeptide exhibiting G-CSF activity and a non-polypeptide moiety
US2003118612A1 G-CSF conjugates
MXPA03011793A Interferon formulations.
ZA200204623B G-CSF conjugates.
AU2002338313A1 Single chain dimeric polypeptides derived from the vegf family
AU2002252971B2 Interferon gamma polypeptide variants
CZ20033016A3 Interferon gamma polypeptide variants
US7038015B2 Interferon gamma polypeptide variants